The Forward P/E of Genoway SA (ALGEN.PA) is N/A.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.
Ticker | Name | Value |
---|---|---|
IPH.PA | Innate Pharma SA | 16.68 |
SPRINT.ST | Sprint Bioscience AB | 1.05 |
RENE.L | ReNeuron Group PLC | 1820.39 |